Functions of 5-HT2A receptor and its antagonists in the cardiovascular system
- 31 October 2004
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 104 (1) , 59-81
- https://doi.org/10.1016/j.pharmthera.2004.08.005
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- AT-1015, a novel serotonin2A receptor antagonist, improves resaturation of exercised ischemic muscle in hypercholesterolemic rabbitsJournal of Vascular Surgery, 2004
- Sarpogrelate, a specific 5ht2‐receptor antagonist, improves the coronary microcirculation in coronary artery diseaseClinical Cardiology, 2002
- N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: A Potent, Selective, and Orally Active 5-HT1F Receptor Agonist Potentially Useful for Migraine TherapyJournal of Medicinal Chemistry, 2001
- Stimulation of 5-HT2A receptors on astrocytes in primary culture opens voltage-independent Ca channelsNeurochemistry International, 1998
- Immunohistochemical localisation of the serotonin 5‐HT2B receptor in mouse gut, cardiovascular system, and brainFEBS Letters, 1996
- Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypesBiochemical and Biophysical Research Communications, 1991
- Syntheses and platelet aggregation inhibitory and antithrombotic properties of [2-[(.omega.-Aminoalkoxy)phenyl]benzenesJournal of Medicinal Chemistry, 1990
- Serotonin induced vasodilatation in the human forearm is antagonized by the selective 5-HT3 receptor antagonist ICS 205–930Life Sciences, 1988
- Inhibition of 5-hydroxytryptamine-induced and-amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonistInflammation Research, 1982
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981